Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gras

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Molecular Immunology|July 1, 1988
Influence of helical organization on immunogenicity and antigenicity of synthetic peptidesH Gras-Masse, M Jolivet, H Drobecq, et al.
Infection and Immunity|June 1, 1987
Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrierM E Jolivet, F M Audibert, H Gras-Masse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1993
Schistosoma mansoni 28-kDa glutathione S-transferase and immunity against parasite fecundity and egg viability. Role of the amino- and carboxyl-terminal domainsC B Xu, C Verwaerde, H Gras-Masse, et al.
Immunology Letters|October 12, 2001
Lipopeptide presentation pathway in dendritic cellsA Hosmalin, M Andrieu, E Loing, et al.
European Journal of Immunology|November 22, 1997
Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigenD A Fidock, V Pasquetto, H Gras, et al.
Vaccine|October 1, 1994
Effect of a lipopeptidic formulation on macrophage activation and peptide presentation to T cellsF Rouaix, H Gras-Masse, C Mazingue, et al.
FEBS Letters|October 20, 1999
Direct evidence of cytoplasmic delivery of PKC-alpha, -epsilon and -zeta pseudosubstrate lipopeptides: study of their implication in the induction of apoptosisK Thiam, E Loing, D Zoukhri, et al.
Vaccine|April 1, 1996
Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTLB Deprez, J P Sauzet, C Boutillon, et al.
Peptide Research|July 1, 1992
Synthetic vaccines and HIV-1 hypervariability: a "mixotope" approachH Gras-Masse, J C Ameisen, C Boutillon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1992
Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoproteinF Martinon, H Gras-Masse, C Boutillon, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Molecular Immunology|July 1, 1988
Influence of helical organization on immunogenicity and antigenicity of synthetic peptidesH Gras-Masse, M Jolivet, H Drobecq, et al.
Infection and Immunity|June 1, 1987
Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrierM E Jolivet, F M Audibert, H Gras-Masse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1993
Schistosoma mansoni 28-kDa glutathione S-transferase and immunity against parasite fecundity and egg viability. Role of the amino- and carboxyl-terminal domainsC B Xu, C Verwaerde, H Gras-Masse, et al.
Immunology Letters|October 12, 2001
Lipopeptide presentation pathway in dendritic cellsA Hosmalin, M Andrieu, E Loing, et al.
European Journal of Immunology|November 22, 1997
Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigenD A Fidock, V Pasquetto, H Gras, et al.
Vaccine|October 1, 1994
Effect of a lipopeptidic formulation on macrophage activation and peptide presentation to T cellsF Rouaix, H Gras-Masse, C Mazingue, et al.
FEBS Letters|October 20, 1999
Direct evidence of cytoplasmic delivery of PKC-alpha, -epsilon and -zeta pseudosubstrate lipopeptides: study of their implication in the induction of apoptosisK Thiam, E Loing, D Zoukhri, et al.
Vaccine|April 1, 1996
Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTLB Deprez, J P Sauzet, C Boutillon, et al.
Peptide Research|July 1, 1992
Synthetic vaccines and HIV-1 hypervariability: a "mixotope" approachH Gras-Masse, J C Ameisen, C Boutillon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1992
Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoproteinF Martinon, H Gras-Masse, C Boutillon, et al.
Pageof 15